Ron Hill

Ron Hill has a diverse work experience in the pharmaceutical and medical industry. Ron currently works as a Key Account Manager for Biotheranostics, Inc. starting in 2022. Prior to that, they served as a Senior Clinical Oncology Specialist at Puma Biotechnology, Inc. from 2019 to 2022.

From 2016 to 2019, Ron worked as a Biosimilars Portfolio Representative at Pfizer, where they successfully launched three biosimilar medications and achieved formulary wins and product orders in multiple accounts. Ron also served as a regional expert in reimbursement, purchasing strategy, and business analytics.

Before joining Pfizer, Ron was a Territory Manager at The Medicines Company from 2013 to 2016. There, they sold hospital IV medications for various treatments and launched the IV platelet inhibitor, KENGREAL, gaining multiple hospital wins.

From 2009 to 2013, Ron worked as a Territory Manager at Olympus, where they sold capital and disposable electrosurgical products. Ron was responsible for driving capital sales and developing pricing strategies.

Ron's career started at Eli Lilly and Company in 2006, where they worked as a Professional Sales Representative. Ron built strong relationships with physicians and staff and successfully marketed and sold Lilly products related to Diabetes and Erectile Dysfunction.

Ron Hill attended Ohio University from 2000 to 2004, earning a Bachelor of Science (BS) degree in Education/History/Political Science. Following this, they pursued further education at Salem University from 2005 to 2006, where they obtained a Master of Arts (MA) degree in Educational Leadership and Administration, General.